SHSE:600129's PB Ratio is ranked worse than 62.35% of 919
companies
in the Drug Manufacturers industry
Industry Median: 1.9
vs SHSE:600129: 2.56
During the past 12 months, Chongqing Taiji Industry (Group) Co's average Book Value Per Share Growth Rate was 1.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 4.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 3.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Chongqing Taiji Industry (Group) Co was 35.60% per year. The lowest was -10.70% per year. And the median was 3.90% per year.
Back to Basics: PB Ratio
Chongqing Taiji Industry (Group) Co (SHSE:600129) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Chongqing Taiji Industry (Group) Co PB Ratio Related Terms
Chongqing Taiji Industry (Group) Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Taiji Industry (Group) Co PB Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Chongqing Taiji Industry (Group) Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chongqing Taiji Industry (Group) Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chongqing Taiji Industry (Group) Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Chongqing Taiji Industry (Group) Co's PB Ratio falls into.
Chongqing Taiji Industry (Group) Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Chongqing Taiji Industry (Group) Co (SHSE:600129) has a PB Ratio of 2.56 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Chongqing Taiji Industry (Group) Co and its competitors. This is 24% below median its historical median of 3.37. Over the past decade, Chongqing Taiji Industry (Group) Co's PB Ratio has ranged from 1.42 to 11.39. According to the industry distribution chart, Chongqing Taiji Industry (Group) Co ranks #573 out of 919 companies in the Drug Manufacturers industry, placing it in the top 62.4%.
Is Chongqing Taiji Industry (Group) Co's PB Ratio too high?
Chongqing Taiji Industry (Group) Co's current PB Ratio of 2.56 is 24% below median its 10-year median of 3.37. Over the past 10 years, this metric has ranged from a low of 1.42 to a high of 11.39. The Drug Manufacturers industry median PB Ratio is 1.90. Chongqing Taiji Industry (Group) Co's value of 2.56 is 34.7% above this industry median. Based on the distribution chart, Chongqing Taiji Industry (Group) Co ranks #573 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Chongqing Taiji Industry (Group) Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Taiji Industry (Group) Co's PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chongqing Taiji Industry (Group) Co ranks #573 out of 919 companies for PB Ratio. This places Chongqing Taiji Industry (Group) Co in the lower half of its industry. The industry median PB Ratio is 1.90. Chongqing Taiji Industry (Group) Co's value of 2.56 is 34.7% above this benchmark. Historically, Chongqing Taiji Industry (Group) Co's own PB Ratio has ranged from 1.42 to 11.39 over the past decade. While the company's 10-year median is 3.37 vs. the industry median of 1.90, Chongqing Taiji Industry (Group) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.90, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chongqing Taiji Industry (Group) Co's current PB Ratio of 2.56 is 34.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Chongqing Taiji Industry (Group) Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Taiji Industry (Group) Co's current PB Ratio is 2.56, which is 24% below median its own 10-year median of 3.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Taiji Industry (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Taiji Industry (Group) Co (SHSE:600129) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.80, compared to a current price of ¥16.58 — trading 20.3% below its estimated fair value. The current PB Ratio is 2.56, which is 24% below median its 10-year median of 3.37 and 34.7% above the Drug Manufacturers industry median of 1.90. Chongqing Taiji Industry (Group) Co's overall GF Score™ is 67/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Chongqing Taiji Industry (Group) Co (SHSE:600129), the current PB Ratio is 2.56 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chongqing Taiji Industry (Group) Co (SHSE:600129) Overvalued in 2026?
Based on GuruFocus' analysis, Chongqing Taiji Industry (Group) Co stock appears to be undervalued.
The current stock price of ¥16.58 is trading 20.3% below its estimated GF Value™ of ¥20.80.
GuruFocus considers Chongqing Taiji Industry (Group) Co to be Modestly Undervalued.
Key valuation signals for SHSE:600129:
PB Ratio: 2.56 (24% below median its 10-year median of 3.37)
GF Value™: ¥20.80 vs. price of ¥16.58 (20.3% below fair value)
Industry Position: 34.7% above the Drug Manufacturers median (#573 of 919)
No single metric tells the full story. See the SHSE:600129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chongqing Taiji Industry (Group) Co Business Description
Chongqing Taiji Industry (Group) Co Ltd is a China-based company engaged in the production and sales of Chinese and Western medicines. It is also engaged in the cultivation of medicinal herbs. Its products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series, and injections. The company mainly conducts its business in domestic and overseas markets.
67GF Score
Get the complete analysis for SHSE:600129
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600129 has been successfully added to your 
